Skip to Main Content

Author Details

John S Schieffelin
Tulane University
2007
93
27
PMIDPaper TitleJournal TitlePublished Year
37531047Ebola Virus Disease Sensitization: Community-Driven Efforts in Sierra Leone.J Community Health2024
36065768Post-Ebola Symptoms 7 Years After Infection: The Natural History of Long Ebola.Clin Infect Dis2023
37749485Antibiotic prescribing practices for acute respiratory illness in children less than 24 months of age in Kenema, Sierra Leone: is it time to move beyond algorithm driven decision making?BMC Infect Dis2023
37649617Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 Community Research Partnership.Vaccine X2023
37816008Respiratory virus surveillance in hospitalized children less than two-years of age in Kenema, Sierra Leone during the COVID-19 pandemic (October 2020- October 2021).PLoS One2023
36993465Novel Tools for Lassa Virus Surveillance in Peri-domestic Rodents.medRxiv2023
37106159Lassa Fever Natural History and Clinical Management.Curr Top Microbiol Immunol2023
36996258A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.PLoS One2023
36758101Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study.PLoS Negl Trop Dis2023
36322544Social distancing, community stigma, and implications for psychological distress in the aftermath of Ebola virus disease.PLoS One2022
35765315Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies.Open Forum Infect Dis2022
35862953Zika Virus Replication in a Mast Cell Model is Augmented by Dengue Virus Antibody-Dependent Enhancement and Features a Selective Immune Mediator Secretory Profile.Microbiol Spectr2022
35850699The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone.BMC Infect Dis2022
36441765Expansion of CD8+ T cell population in Lassa virus survivors with low T cell precursor frequency reveals durable immune response in most survivors.PLoS Negl Trop Dis2022
35895416Evaluation of Three Clinical Prediction Tools to Predict Mortality in Hospitalized Patients with Lassa Fever.Am J Trop Med Hyg2022
33974565What should define a SARS-CoV-2 "breakthrough" infection?J Clin Invest2021
33852832A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus.Immunity2021
33742724New-onset atrial arrhythmias associated with mortality in black and white patients hospitalized with COVID-19.Pacing Clin Electrophysiol2021
33822010Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone.Clin Infect Dis2021
33788861Boosting understanding of Lassa Fever virus epidemiology: Field testing a novel assay to identify past Lassa Fever virus infection in blood and oral fluids of survivors and unexposed controls in Sierra Leone.PLoS Negl Trop Dis2021
33809204Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012-2019.Microorganisms2021
33725951Clinical features and viral RNA shedding of imported and local cases with COVID-19 in Wenzhou, China.Medicine (Baltimore)2021
35262027SARS-CoV-2 seroprevalence rates of children seeking medical care in Louisiana during the state stay at home order.J Clin Virol Plus2021
34835131Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans.Viruses2021
34452470The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and Response.Viruses2021
34242218Implementation of the Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) study: Lessons learned for vision health systems strengthening in Sierra Leone.PLoS One2021
34260615Health seeking behavior after the 2013-16 Ebola epidemic: Lassa fever as a metric of persistent changes in Kenema District, Sierra Leone.PLoS Negl Trop Dis2021
31301137Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses.J Infect Dis2020
31693114Long-term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of Inflammation.Clin Infect Dis2020
33079033Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever.Emerg Infect Dis2020
33243278Elevated L-threonine is a biomarker for Lassa fever and Ebola.Virol J2020
33301526Ophthalmic manifestations and vision impairment in Lassa fever survivors.PLoS One2020
33241780Lassa Fever among Children in Eastern Province, Sierra Leone: A 7-year Retrospective Analysis (2012-2018).Am J Trop Med Hyg2020
32600820Responses of three urban U.S. Children's Hospitals to COVID-19: Seattle, New York and New Orleans.Paediatr Respir Rev2020
32994446Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.Sci Rep2020
32795603Lassa Fever Induced Hearing Loss: The Neglected Disability of Hemorrhagic Fever.Int J Infect Dis2020
32500851African Resources and the Promise of Resilience against COVID-19.Am J Trop Med Hyg2020
32436943Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae.J Infect Dis2020
32142546High crossreactivity of human T cell responses between Lassa virus lineages.PLoS Pathog2020
32269122Identification of Common CD8<sup>+</sup> T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone.J Virol2020
32266932Infectious Disease Outbreaks: The Need For an All-in Approach.J Infect Dis2020
32401577Fatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2c).Fetal Pediatr Pathol2020
32457420Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak.Sci Rep2020
30788396Data set on Lassa fever in post-conflict Sierra Leone.Data Brief2019
31258424Congenital Cytomegalovirus Infection.Ochsner J2019
31333155A Review of Hearing Loss Associated with Zika, Ebola, and Lassa Fever.Am J Trop Med Hyg2019
30926957New filovirus disease classification and nomenclature.Nat Rev Microbiol2019
30921383A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges.PLoS One2019
31094312Emerging Trends in Clinical Tropical Medicine Research.Am J Trop Med Hyg2019
30703150Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar.PLoS One2019
  • 1 - 50 of 93

Recommended Authors

University of California San Francisco School of Medicine
Career Start Year 2018
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 2018
Number of shared co-authors 0
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 2
US Centers for Disease Control and Prevention
Career Start Year 2014
Number of shared co-authors 1
Division of Clinical Microbiology, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2011
Number of shared co-authors 1
Hinton State Laboratory Institute
Career Start Year 2009
Number of shared co-authors 12
University of Washington Medical Center
Career Start Year 2008
Number of shared co-authors 11
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 0
Stanford University
Career Start Year 2007
Number of shared co-authors 0
Stanford University
Career Start Year 2006
Number of shared co-authors 0
University of Kansas Medical Center
Career Start Year 2006
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2004
Number of shared co-authors 1
University of Minnesota
Career Start Year 2003
Number of shared co-authors 5
U.S. Centers for Disease Control and Prevention
Career Start Year 2002
Number of shared co-authors 3
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 7
University of Maryland
Career Start Year 2000
Number of shared co-authors 0
Marshfield Clinic Research Institute, Marshfield Clinic Health System
Career Start Year 1995
Number of shared co-authors 4
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 0
UCSF School of Medicine, University of California Health
Career Start Year 1993
Number of shared co-authors 1
Oak Crest Institute of Science
Career Start Year 1992
Number of shared co-authors 1
United States Zucker School of Medicine at Hofstra/Northwell
Career Start Year 1992
Number of shared co-authors 1
University of California-San Francisco
Career Start Year 1991
Number of shared co-authors 15
Yale University School of Medicine
Career Start Year 1989
Number of shared co-authors 4
University of Utah
Career Start Year 1987
Number of shared co-authors 5
Instituto Goncalo Moniz, Yale School of Public Health
Career Start Year 1983
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 1981
Number of shared co-authors 3
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 5
NYU Grossman School of Medicine, NY Clinical Laboratories
Career Start Year 1975
Number of shared co-authors 0
University of California berkeley
Career Start Year 1971
Number of shared co-authors 0

Collaborators

Tulane University School of Medicine
Co-authored papers 45
Harvard University
Co-authored papers 19
London School of Hygiene & Tropical Medicine
Co-authored papers 12
University of North Carolina School of Medicine
Co-authored papers 9
Infectious Disease Institute, Makerere University
Co-authored papers 8
Christchurch Hospital
Co-authored papers 7
Broad Institute of MIT and Harvard
Co-authored papers 6
The University of North Carolina School of Medicine
Co-authored papers 6
Institute of Health Policy
Co-authored papers 6
University of Liverpool
Co-authored papers 5
Royal Liverpool Hospital
Co-authored papers 5
Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard
Co-authored papers 5
College of Public Health, University of Nebraska Medical Center
Co-authored papers 4
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 4
US Centers for Disease Control and Prevention
Co-authored papers 4
Geneva Center for Emerging Viral Diseases, Geneva University Hospitals
Co-authored papers 4
Co-authored papers 4
Universite de Sherbrooke
Co-authored papers 4
University of British Columbia
Co-authored papers 3
Emory University School of Medicine
Co-authored papers 3
The Center for Genome Architecture, Baylor College of Medicine
Co-authored papers 3
The Scripps Research Institute
Co-authored papers 3
Emory University School of Medicine
Co-authored papers 3
University College London Hospitals National Health Service Foundation Trust
Co-authored papers 3
F.I. Proctor Foundation
Co-authored papers 3
Co-authored papers 3
the Scripps Research Institute
Co-authored papers 3
Adachi Mental Clinic
Co-authored papers 3
Ministry of Health
Co-authored papers 2
Boston University
Co-authored papers 2